logo

For the Inventor, By the Inventor

Col. Campestre Churubusco, Mexico

Alicia Cervantes

This inventor holds 8 USPTO granted patents. Top assignees: Syntex (u.s.a.) Inc., Other. Active years: 1995-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alicia Cervantes. Retrieved from https://idiyas.com/inventor/alicia-cervantes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 17.2

ph-index = 6

Forward Citations = 117(Granted Patents)


Location History:

  • Palo Alto, CA (US) (1996)
  • Mexico City, MX (1996)
  • Mexico D. F., MX (1996)
  • Col. Campestre Churubusco, MX (1995 - 1997)

Company Filing History:

goldMedal7 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
silverMedal1 out of 834,513 
Other
 patents

Years Active: 1995-1997

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5633279 - 5-substituted derivatives of mycophenolic acid (1997-05-27),
2. 5554612 - 4-amino 6-substitutes mycophenolic acid and derivatives (1996-09-10),
3. 5538969 - 4-amino derivatives of 5-substituted mycophenolic acid (1996-07-23),
4. 5536747 - 6-substituted mycophenolic acid and derivatives (1996-07-16),
5. 5525602 - Method of using 4-amino 6-substituted mycophenolic acid and derivatives (1996-06-11),
6. 5512568 - Method of using 4-amino derivatives of 5-substituted mycophenolic acid (1996-04-30),
7. 5493030 - 5-substituted derivatives of mycophenolic acid (1996-02-20),
8. 5444072 - 6-substituted mycophenolic acid and derivatives (1995-08-22),

Title: Alicia Cervantes: Innovator in Therapeutic Agents

Introduction

Alicia Cervantes is a prominent inventor based in Col. Campestre Churubusco, Mexico. She has made significant contributions to the field of therapeutic agents, holding a total of eight patents. Her work focuses on developing innovative solutions for various medical conditions.

Latest Patents

Cervantes' latest patents include the development of 5-substituted derivatives of mycophenolic acid. These hexenoic acid side-chain derivatives are recognized as therapeutic agents beneficial in treating disease states indicated for mycophenolic acid and/or mycophenolate mofetil. This includes conditions such as immune, inflammatory, tumor, proliferative, viral, or psoriatic disorders. Another notable patent is for 4-amino 6-substituted mycophenolic acid and its derivatives. These derivatives are also advantageous in treating disease states indicated for mycophenolic acid and/or mycophenolate mofetil, as well as other immunosuppressant agents.

Career Highlights

Throughout her career, Cervantes has worked with various companies, including Syntex (U.S.A.) Inc. Her experience in the pharmaceutical industry has allowed her to contribute significantly to the development of therapeutic agents.

Collaborations

Cervantes has collaborated with notable individuals in her field, including David John Morgans, Jr. and David Bernard Smith. These collaborations have further enhanced her research and development efforts.

Conclusion

Alicia Cervantes is a remarkable inventor whose work in therapeutic agents has the potential to impact many lives. Her innovative patents and collaborations highlight her dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…